Test
345 articles
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
Pancreatic Cancer During the Pandemic
Barbara Wojciechowski was diagnosed with pancreatic cancer as the pandemic was rising, affecting her family support during treatment.
A Life-Saving, Life-Changing Diagnosis
Randi C. Ervin’s primary care doctor suspected she had something more than prediabetes. Testing showed pancreatic neuroendocrine cancer.
Learning to Recognize the Symptoms of Pancreatic Cancer
Recognizing the symptoms of pancreatic cancer is key to early detection. Laura Metzger’s story illustrates the importance of detecting pancreatic cancer early.
Tomorrow Is a New Day
Abby Pezzulo was an active young working mother when she was diagnosed with a pancreatic neuroendocrine tumor.
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
Endurance Athlete Enduring Pancreatic Cancer Treatment
After a stage IV pancreatic cancer diagnosis, Dr. Kevin Moore had cytoreductive surgery to remove the metastases in his abdomen.
Go Live Your Life
After his pancreatic cancer diagnosis, Dean Jackson took his treatment of chemotherapy, radiation, and a Whipple procedure step by step.
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
Standard of Care Plus
Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
Damage as a Way to Repair Pancreatic Cancer
Dr. Talia Golan takes a closer look at the damage caused by the BRCA1/2 mutations to find a way to treat pancreatic cancer.
Inhibiting Cell Division With Alternating Electric Fields
Dr. Andrew Coveler explains how electric fields are being used to disrupt pancreatic cancer cell division, to make tumors more removable.